Come curare il mal di schiena: la bibliografia

di Matteo Longhi, U.O. di Reumatologia, IRCCS, Istituto Ortopedico Galeazzi, Milano

(leggi tutto l’articolo)


  1. Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine. 1995;20:11-9
  2. Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine. 2006;31:2724-7
  3. Wynne-Jones G, Cowen J, Jordan JL, et al. Absence from work and return to work in people with back pain: a systematic review and meta-analysis. Occup Environ Med 2014;71: 448-56
  4. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008;8:8-20
  5. Costa-Black KM, Loisel P, Anema JR, et al. Back pain and work. Best Pract Res Clin Rheumatol 2010 ;24):227-40
  6. Anema JR, van der Beek AJ. Medically certified sickness absence. Br Med J 2008;337:825-6
  7. Balagué F, Mannion AF, Pellis_e F, et al. Non-specific low back pain. Lancet 2012;379:482-91
  8. Pransky G, Buchbinder R, Hayden J. Contemporary low back pain research – and implications for practice. Best Pract Res Clin Rheumatol 2010 24:291-8
  9. Jeffries LJ, Milanese SF, Grimmer-Somers KA. Epidemiology of adolescent spinal pain: a systematic overview of the research literature. Spine 2007; 32: 2630–37
  10. Greenhalgh S, Selfe J. A qualitative investigation of Red Flags for serious spinal pathology. Physiotherapy 2009; 95: 224–27
  11. vanTulder M, Becker A, Bekkering T, et al. Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006; 15 (suppl 2): S 169–91
  12. Dionne CE, Dunn KM, Croft PR, et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine 2008; 33: 95–103
  13. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992; 50: 133–49
  14. Krismer M, van Tulder M. Strategies for prevention and management of musculoskeletal conditions. Low back pain (non-specifi c). Best Pract Res Clin Rheumatol 2007; 21: 77–91
  15. Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for low back pain: systematic review and meta-analysis. Lancet 2009; 373: 463–72
  16. Chou R, Qaseem A, Owens DK, Shekelle P, for the Clinical Guidelines Committee of the American College of Physicians. Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med 2011; 154: 181–89
  17. Chou R. Pharmacological management of low back pain. Drugs 2010; 70: 387–402
  18. Koes B, Scholten R, Mens J, et al. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis. 1997; 56: 214–23
  19. Bhattarai S, Chhetri HP, Alan K, et al.  A Study on Factors Affecting Low Back Pain and Safety and Efficacy of NSAIDs in Acute Low Back Pain in a Tertiary Care Hospital of Western Nepal. J Clin Diagnostic Res. 2013;7: 2752-8
  20. Berry H, Bloom B, Hamilton EBD et al. Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain. Ann Rheum Dis 1982; 41: 129-32
  21. Valtonen EJ. A comparative short-term trial with Voltaren (diclofenac sodium) and naproxen in soft-tissue rheumatism. Scand J Rheumatol 1978; 22 s: 69-73
  22. Friedman BW, Dym AA, Davitt M, et al. Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain A Randomized Clinical Trial. Jama 2015; 314: 1572-80
  23. Pelletier JP, Pelletier JM, Rannou F, et al. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Sem Arthritis  Rheum 2016; 45: S22–S27
  24. Lanza FL, Chan FK, Quigley EM. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009; 104: 728-38
  25. NICE advice (KTT 13): Non-steroidal anti-inflammatory drugs.